Objectives: The nuclear factor κB regulates the expression of genes involved in many processes that play a key role in the development and progression of cancer. The aim of this study was to examine the infl uence of the alpha lipoic acid in the chemoprevention of colon and cervix carcinoma in vitro. Background: In recent years, special attention has been paid to the potential chemopreventive properties of antioxidants. There are no published data on the impact of alpha lipoc acid of chemoprevention of cervix and colon cancer. Methods: We examined the effect of alpha lipoic acid alone or in combination with cisplatin and 5-fl uorouracil on proliferation of the two cell lines, HeLa (human cervical carcinoma cells) and Caco-2 (human colon cancer cells) by MTT test. The measurement of the level of transcription factor NF-κB was also performed in the cells of both cell lines. Results: At least one of the mechanisms of the antiproliferative and/or cytotoxic effect of alpha lipoic acid on Caco-2 and HeLa cells at high concentrations, the transcription factor NF-κB, may be involved, as well as the products of transcription of genes that are under its control. Conclusion: The alpha lipoic acid has proven to be a promising candidate in the combat arena against cancer (Tab. 4, Ref. 31). Text in PDF www.elis.sk.
Colon cancer is a highly frequent form of malignancy (1) . It is considered the third most common malignancy diagnosed in the population of Europe and as such is a major health and socioeconomic problem (2) . Cervix cancer with its incidence being slightly more common than colon carcinoma, takes the second place and has recorded an increase in the number of patients in developing countries (3) . Chemoprevention may be one of the most important components of cancer prevention and is based on the use of chemical agents from the nature that surrounds us, as well as synthetic analogues, which may block tumor initiation and promotion of events, which mark stages in the development of tumors (4) . A new approach to cancer chemoprevention is based on coadministration of two or more substances, of different mode of effect, the aim of which is to intensify the activity, which would bring down side-effects to a minimum (5) .
In recent years, special attention has been paid to the potential chemopreventive properties of antioxidants. Alpha lipoic acid (ALA) is one of the most effi cient known endogenous antioxidants, and in recent years has taken a special place as an anticancer agent (6) . ALA shows an antiproliferative effect and inhibits the growth of colon cancer cells in vitro (7, 8) . The activation of transcription factor nuclear factor-kappa B (NF-κB) regulates various genes involved in the proliferation, invasion, angiogenesis, and metastasis of cancer cells. NF-κB is important to study in solid tumors because of its potential to act downstream of a number of oncogenic pathways making it a desirable therapeutic target with potential for activity across a broad range of cancers (9) . There are no published data on the impact of ALA on cervix carcinoma cells, nor data about the impact of chemoprevention of colon and cervix cancer. Therefore, the aim of this study was to examine the infl uence of the alpha lipoic acid in the chemoprevention of colon and cervix carcinoma in vitro.
Materials and methods

Chemicals
following substances were purchased for experiments: alpha lipoic acid, cisplatin and 5-fl uorouracil as follows: alpha lipoic acid (Berlition ED 300, Berlin-Chemie, Germany, 300 mg/12 ml), cisplatin (Cisplatin Ebewe, Ebewe Pharma Austria, 10 mg/20 ml) and 5-fl uorouracil (Fluorouracil Teva, Pharmachemie BV -Netherlands, 50 mg/ml). DMEM (Dulbecco's Modifi ed Eagle Medium), FBS (Fetal Bovine Serum), Antibiotic-Antimycotic solution, L-Glutamine and Trypsin-EDTA solution were purchased from PAA Laboratories, Austria and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was purchased from Carl Roth, Germany. Trypan Blue Stain was purchased from Invitrogen. Primary anti-NF-κB antibody and secondary antibody were purchased from Santa Cruz Biotechnology (C-20:sc-372 epitope mapping at C-terminalals of NF-κB, Santa Cruz, CA, USA). Cytostatics -5-fl uorouracil and cisplatin, according to the protocol, are used in the treatment of colon and cervix carcinoma (10, 11) .
Concentration for in vitro study
Alpha lipoic acid (ALA), cisplatin (CP) and 5-fl uorouracil (5-FU) were diluted in DMEM and three concentrations of each of these substances were tested (group 1 -the lowest concentration, group 2 -middle concentration and group 3 -the highest concentration). Final concentrations of the tested substances were the following: 10, 100 and 1000 μM of alpha lipoic acid, 1.66, 3.32 and 6.64 μM of cisplatin and 10, 100 and 1000 μM of 5-fl uorouracil. We have also combined alpha lipoic acid with cisplatin and 5-fl uorouracil, respectively. Combining was performed using substance concentrations from the same group as the following: group 1 with group 1, group 2 with group 2 and group 3 with group 3 in the ratio 1:1 so that the effective concentrations of substances in combinations were twice less than the concentrations of substances that were applied alone
Cell lines
For this experiment, we used two cell lines, HeLa S3 (human cervical carcinoma cells) which were obtained from the Leibniz Institute DSMZ and Caco-2 (human colon cancer cells) which were obtained from ATCC. Cells were cultured in DMEM supplemented with 10 % FBS, 2 mM L-glutamine, and antibiotic/antimycotic solution at 37 °C in an atmosphere with 5 % CO 2 and saturated humidity. Replacement of the culture medium was performed every 2 to 3 days.
Cell proliferation assay
When cells of both cell lines reached approximately 80 % confl uence, the cells were harvested using Trypsin/EDTA solution, washed in buffer solution and the total number of cells was determined by Trypan blue dye exclusion test. Cells were planted in 96 well plates at density 2 x 10 4 cells per well and cultured for 24 hours under standard cell culture conditions. After that the examined substances, alone or combined, were added to the cells in the tested concentrations. As a control, we used cells that were incubated only with completed cell culture medium supplement with FCS without additional substances. The effect of tested substances on cell proliferation was determined after 48 hours of incubation by performing MTT test.
MTT test
MTT test is based on the reduction of MTT to purple formazan crystals that are insoluble in water. The medium, in which the cells were incubated with or without additional substances, was discarded at the end of the incubation period. Cells were washed with buffer solution and 20 μL of MTT solution was added to each well at concentration of 1 mg/ml. Three hours after incubation of cells with MTT at 37 °C, the resulting formazan crystals were dissolved with 100 μL of 2-propanol. Spectrophotometric measurement of MTT reduction, or intensity of the purple color, was performed at a wavelength of 540 nm on an ELISA plate reader (Multiscan Ascent, Thermo Labsystems). The intensity of purple color was in direct correlation with the number of viable cells. Results are presented as the average value of absorbance ± standard deviation from four to eight replications for all tested substances as well as control.
Measurement of the level of transcription factor NF-κB
The cells of both cell lines were seeded into 96 well plates with the density of 3x10 4 cells/well, respectively, and cultivated in the standard cell culture conditions for 24 hours. After that period, the substances were added in concentrations and combinations, examined, and the cells were incubated for the next 48 hours. Further protocol was performed according to the Kocic (12) . Briefl y, the cells were washed in PBS and fi xed by using 70 % methanol and permeabilized with 0.1% Triton PBS. The cells were incubated with the primary anti-NF-κB antibody, washed three times, and incubated with the FITC-conjugated secondary antibody. The mean fl uorescence intensity (MFI; logarithmic scale) of the cells was determined and analyzed on a Victor ™ multiplate reader (Perkin Elmer-Wallace, Wellesley, MA). The results presented were obtained following the subtraction of blank values treated with the secondary antibodies only.
Statistical analysis
The data were analyzed by the means of commercially available statistics software package (SPSS for Windows ®, v. 17.0, Chicago, USA) using the Students' t-test and the ANOVA test. The results were presented via ± / SD. The statistical signifi cance was set to p < 0.05.
Results
The results of the MTT test after incubating the Caco-2 cells with the substances are shown in Table 1 .
The T-test of the independent samples was compared to the testing results of the alpha lipoic acid at three different concentrations on the proliferation in the culture Caco-2 cells compared to the control group (cells in medium without additional active substances). There was a signifi cant reduction in the proliferation in dose-dependent manner (pALA3 < 0.001 and pALA2 < 0.001). The ANOVA showed a statistical signifi cance between groups ALA1, ALA2 and ALA3 (p < 0.001). Subsequent comparisons using the Tukeyev HSD test indicated that the mean values of all the groups were statistically signifi cantly different (pALA32 = 0.004, pALA31 < 0.001 and pALA21 < 0.001).
In the groups treated with cisplatin, there was a statistical signifi cance compared to the control group only for Group 3 (p < 0.001, pCP3 < 0.001) and Group 1 (p < 0.05, pCP1 = 0.010). The ANOVA examined the statistical signifi cance between the groups CP1, CP2 and CP3 (pCP < 0.001). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of the CP3 group was different from the CP1 and CP2 groups (pCP32 < 0.001 and pCP31 < 0.001). In groups treated with 5-fl uorouracil, there was a statistical signifi cance compared to the control group in Group 3 (p < 0.01, pFU3 = 0.007). The combination of alpha lipoic acid /cisplatin, as compared to the control group, showed a statistically signifi cant inhibition proliferation in the Group 3 (p < 0.001, pALA-CP3 < 0.001) and Group 2 (p < 0.05, pALA-CP2 = 0.013). The ANOVA examined the statistical signifi cance between the groups ALA-CP1, ALA-CP2 and ALA-CP3. There was a statistically signifi cant difference at the level of pALA-CP < 0.001. Subsequent comparisons using the Tukeyev HSD test, showed that the mean value in the ALA-CP3 group differed from those in groups ALA-CP2 and ALA-CP1 (pALA-CP32 < 0.001 and pALA-CP31 < 0.001).
The combination of alpha lipoic acid/fl uorouracil in the highest dose, compared to the control group, showed to be statistically signifi cant (p < 0.001, pALA-FU3 < 0.001) and in the Group 2 (p < 0.01, pALA-FU2 = 0.009). The ANOVA showed a statistical signifi cance between the groups ALA-FU1, ALA-FU2 and ALA-FU3. There was a statistically signifi cant difference at the level of pALA-FU < 0.001. Subsequent comparisons using the Tukeyev HSD test showed that the mean value in the LC3 group differed from those in the groups ALA-FU1 and ALA-FU2 (pALA-FU3-2 < 0.001 and pALA-FU3-1 < 0.001.)
The results of the MTT test after incubating the HeLa cells with the tested substances are shown in Table 2 .
The T-testing of the independent samples was compared to the results of the alpha lipoic acid at three different concentrations on the cultured cell proliferation compared to the control group. A signifi cant reduction in cell proliferation was in dose dependent manner (p < 0.001, pALA3 < 0.001, p < 0.01, pALA2 = 0.004 and pALA1 = 0.001). The ANOVA showed a statistical significance between the groups ALA1, ALA2 and ALA3. There was a statistically signifi cant difference (p < 0.001). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of Group 3 was signifi cantly different than those in the Groups 2 and 1 (pALA32 < 0.001 and pALA31 < 0.001).
All three groups treated with cisplatin showed a statistically signifi cant decrease in cell proliferation compared to the control group (p < 0.001, pCP3 < 0.001, pCP2 < 0.001 and pCP1 < 0.001). Also, there was a statistically signifi cant difference (p < 0.001) estimated by the ANOVA between groups CP1, CP2 and CP3 (pCP < 0.001). Subsequent comparisons using the Tukeyev HSD test indicated that the mean values of the three groups differed signifi cantly (pCP32 = 0.005, pCP31 < 0.001 and pCP21 = 0.003). The combination of alpha lipoic acid / cisplatin as compared to the control group, showed a statistical signifi cance in the Groups 3 and 1 (p < 0.001, pALA-CP3 < 0.001 and pALA-CP1 < 0.001) and Group 2 (p < 0.01, pALA-CP2 = 0.001). The ANOVA recorded a statistical signifi cance between the groups ALA-CP1, ALA-CP2 and ALA-CP3. There was a statistically signifi cant difference (p < 0.01, pALA-CP = 0.005). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of Group 3 signifi cantly differed from those of Groups 2 and 1, pALA-CP32 = 0.010 and pALA-CP31 = 0.006.
In the groups treated with 5-fl uorouracil, a statistical significance was found between the control group and Group 2 (p < 0.001, pFU2 < 0.001), whereas in the Group 3 and 1, the statistical signifi cance was set at p < 0.01, (pFU3 = 0.001 and pFU1 = 0.003). The combination of alpha lipoic acid/5-fl uorouracil in comparison to the control group showed a statistical signifi cance in all three groups, (p < 0.001) in the Group 3, pALA-FU3 < 0.001, and in the Groups 2 (p < 0.01) and 1, pALA-FU2 = 0.005, pALA-FU1 = 0.003. The ANOVA showed statistically signifi cant differences (p < 0.05, pLC = 0.045). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of Group 3 signifi cantly differed from Group 2 (pALA-FU32 = 0.42).
The levels of transcriptional factor NF-κB in the Caco-2 cells culture are shown in Table 3 .
The T-testing of independent samples was compared to the results of the alpha lipoic acid at three different concentrations on the levels of transcriptional factor NF-κB in the Caco-2 cells culture compared to the control group. There was a signifi cant reduction in the levels of NF-κB in culture in the Groups 3 and 1 (p < 0.05, pALa3 = 0.025, pALA1 = 0.025). The ANOVA tested a statistical signifi cance between the groups L1, L2 and L3.
In the groups treated with cisplatin, there was a statistically signifi cant difference in the Group 3 (p < 0.001) and the Group 2 (p < 0.05) compared to the control group (pCP3 = 0.002 and pCP2 = 0.040). In the groups treated with 5-fl uorouracil, a statistical signifi cance was found only between the control group and the Group 2 (p < 0.05, pFU2 = 0.024). The combination of alpha lipoic acid / cisplatin, as compared to the control group, showed a statistical signifi cance only in theGroup 3 (p < 0.01, pALA-CP3 = 0.001).
The ANOVA examined the statistical signifi cance between the groups ALA-CP1, ALA-CP2 and ALA-CP3 (p < 0.01 pALA-CP = 0.009). Subsequent comparisons using the Tukeyev HSD test showed that the mean value in the ALA-CP3 group differed from that in the group ALA-CP1 (pALA-CP31 = 0.007). Combined, alpha lipoic acid/5-fl uorouracil were compared to the control group and the test showed a statistical signifi cance only in the Group 3 (p < 0.001, pALA-FU3 < 0.001). The ANOVA examined the statistical signifi cance between the groups ALA-FU1, ALA-FU2 and ALA-FU3 (p < 0.01 pALA-FU = 0.003). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of group ALA-FU3 was different from those in the groups ALA-FU2 (p ALA-FU32 = 0.008) and ALA-FU1 (p ALA-FU31 = 0.003).
The levels of transcriptional factor NF-κB in the HeLa cells culture are shown in Table 4 .
The T-testing of the independent samples was used to compare the results of the alpha lipoic acid at three different concentrations on the levels of transcriptional factor NF-κB of the cells in culture compared to the control group. There was a signifi cant reduction in cell proliferation in the culture in the group 3, pALA3 < 0.001. The ANOVA examined the statistical signifi cance between the groups ALA1, ALA2 and ALA3 (p < 0.001). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of the group ALA3 differs from those in the groups ALA2 and ALA1 (pALA32 < 0.001 and pALA31 < 0.001).
In the groups treated with cisplatin there were statistically signifi cant differences between all groups compared to the control group, in the Group 3 at p < 0.001, pCP3 < 0.001 and in the other two groups at p < 0.01, = pCP2 0.002 and pCP1 = 0.004. The ANOVA examined the statistical signifi cance between the groups CP1, CP2 and CP3. There was a statistically signifi cant difference (p < 0.05, pCP = 0.025). Subsequent comparisons using the Tukeyev HSD test showed that the mean value of group ALA-CP3 differed from that in the Group ALA-CP1 (pALA-CP31 = 0.026). However, the Group 3 even showed a statistically signifi cant increase (p < 0.05, pFU3 = 0.012). The combination of alpha lipoic acid both with cisplatin and 5-fl uorouracil, showed no statistical signifi cance as compared to both the control group and between the groups themselves.
Discussion
Literature data indicates that the ALA acts as an anti apoptotic agent in a variety of cell cultures, preventing oxidant-induced cell death, and induces apoptosis in cancer cells (13) . The ALA has an anticancerogenic potential due to the self-elimination free radicals, including the hydroxyl radical, which is included in all stages of cancer, and which is considered to be responsible for the increase in the number of metastases. Its highly antiproliferative effect, ALA has shown on the cancer cell lines in the culture (14) . ALA was documented to increase the effectiveness of other antioxidants (vitamin C and E, coenzyme Q10 and glutathione) and signifi cantly increases glutathione levels for 30-70 %, especially in the cells of the liver, lung and kidney of laboratory animals when injected as an antioxidant. The effect of this antioxidant on the glutathione level is important because glutathion signifi cantly affects the synthesis of the harmful cytokines and adhesion molecules that affect NF-κB activity (15) .
In our research, the results of MTT test showed that lipoic acid has strong cytotoxic and/or antiproliferative effects on the Caco-2 cells, especially marked at the highest concentration examined. Combined with standard anticancer drugs, lipoic acid enhances its cytostatic effect, especially marked at the highest concentrations tested making and this effect was even more emphasised when combined with 5-FU.
The MTT test of cell proliferation in culture of the Caco-2 cell line showed the expected effect on the proliferation of cells in the group treated with 5-FU. 5-FU expressed cytostatic effect applied in the highest tested concentration only in the Caco cell line. The effect of the 5-FU on cell proliferation may be considered expected if we take into account the potential of the colon cancer cells to develop the resistance to the action of 5-FU. There are several pathways that may be responsible for the development of the resistance to the action of 5-FU (16) . The thymidylate synthase (TS) participates in methylation reactions with deoksiuridin monophosphate (dump) using the 5.10-methylene tetrahidrofolata for synthesize deoxitimidine monophosphate (dTMP). Because of this essential role in the thymidylate synthase, it may be a target for the action location of chemoprevention agents such as 5-FU and 5-fl uorouracil deoxiribosis. Both drugs are converted to 5-monophosphate fl uorodeoxiuridine (5FdUMP), a nucleotide with a cytotoxic effect achieved by forming a stable complex with thymidylate synthase and folate cofactor (5.10 methylentetrahydropholate). The mechanisms of resistance include increased intracellular levels of thymidylate synthase, the development of mutant forms of the enzyme, and a low affi nity for 5-FdUMP folate cofactors that may later result in reduced activity of thymidylate synthase (17, 18) . Another way of resistance can be explained by a decreased transport of nucleosides and nucleobases in cells by nucleoside / nucleobase transporters (19) , while some authors have found that the p53 status and DNA defects recovery may be important resistance causes (20) .
The HeLa cell line showed a different pattern of response to the applied treatments. MTT test has shown weaker cytotoxic and/ or antiproliferative effect of lipoic acid on HeLa cells compared to Group Cisplatin showed a stronger effect on the HeLa cell line than on the Caco cell lines. The strongest effect was achieved by using the highest concentration of CP3 when the concentration expressed a moderate cytostatic effect in both cell lines. The values, compared to the control, were similar for both cell lines when the highest concentration were used while the difference in effect may be seen at lower concentrations. The highest concentration combination acts as an extreme cytostatic in the Caco-2 cells and as a mild cytostatic in the HeLa cells. Low concentrations of this drug combination showed lower effect on the HeLa cells compared to Caco-2 cells (Tabs 1, 2) .
The NF-κB is an inducible transcription factor that mediates the signal transduction between the nucleus and the cytoplasm in a number of cell types and controls the expression of many genes involved in cell growth, differentiation, apoptosis regulation, cytokine production, and neoplastic transformation (21) . In mammals, the NF-κB is made up of fi ve different elements: RelA (p65), RelB, cRel (Rel), NF-κB1 (p50 as a precursor p105) and NF-κB2 (p52 as a precursor p100). During the stimulation by tumor necrosis factor alpha (TNF-α) or IL-1, viruses and free radicals affect the phosphorylation of the inhibitory molecules (IκB), when it degrades and it becomes an active form of NF-κB (22) . Constitutively increased concentration and induction of NF-κB has been demonstrated in many cancers, including colorectal cancer (23) . The induction of NF-κB leads to the development of the resistance to chemotherapy. On the other hand, it has been found that NF-κB may be a predictor of cellular response to a given chemotherapeutic agent (24) . The data are controversial, because in some therapy procedures, NF-κB positive tumors are more responsive to therapy in a state of advanced colorectal cancer (when applying cetuximab), while other data indicate that NF-κB negative tumors exhibit greater sensitivity to therapy. As a typical inducible transcription factor, NF-κB is activated in conditions of an increased oxidative stress and as such, it is the strongest inducer of the primary infl ammatory response. It has been shown that there is a constitutive induction of NF-κB in the states of increased presence of mucosa and microfl ora during of chronic infl ammation. Chronic infl ammation is a fertile ground for carcinogenesis, suggesting that epigenetic factors can induce differentiation of the cancerous colon, and the presence of elevated concentrations of NF-κB in the tumor tissue favors metastasis. The most likely reason that a combination of cytostatic and alpha lipoic acid exerts an inhibitory effect on the NF-κB levels would be strong antioxidant properties of the alpha lipoic acid, which thereby reduce the inducible effect. But the fact that the ALA applied solely and thus was not being able to completely suppress the synthesis and the activation of the NF-κB, acknowledges that cancer cells produce a constitutive NF-κB not only in response to the epigenetic factors (oxidative stress), but most likely as a mode for their survival (25, 26, 27) . This is why it is inexplicable that the combined use of lipoic acid and 5-FU has resulted in increased effect of the cytostatic applied. Uezsuka et al. showed that the reduction of NF-κB activity induces apoptosis and reduces resistance to 5-FU, suggesting that an increased regulation of the inducible factors may be directly and indirectly associated with cell proliferation and the inhibition of apoptosis (28) .
Similar results exist concerning the HeLa cells. It has been found that the activated NF-κB has a positive effect on cell growth, while inhibiting the activity by forming stable complexes with the inhibitors reduced and slowed the movement of tumor cells in the G2 phase from the cell cycle S period (29) . The results obtained in our study showed that the alpha lipoic acid was also the case when there is resistance to chemotherapy, as is the case for the action of 5-FU on test cells. This only confi rmed the fact that in the case of this type of cancer, there is a constitutive activation of NF and epigenetic -κB, which is even more intense while applying small doses of the alpha lipoic acid or cytostatics. Obtained results together with our data may suggest that it is the most important to apply the adequate dose of the drug.
On several in vitro models have shown that inhibition and reduced activity of NF-κB is associated with decreasing of MTT reduction, which shows that there is cytotoxic, apotototic and/or antiproliferative effect (30, 31) . Our treatments have generally shown that decrease of NF-κB activity went along with the decline of MTT test values. Since the inhibition of growth of cancerous cells HeLa and Caco-2 was associated with the inhibition of NF-κB, this powerful transcription factor in the regulation of cell fate can be one of the ways through which the antiproliferative effect of ALA performed.
Conclusion
The data showed that chemotherapy in treating colon and cervix cancer should be conducted in accordance with the possible epigenetic effects and constitutive state of the cellular determinants of survival. The combination of the alpha lipoic acid with conventional cytostatic treatment achieved the best effects at highest doses. According to our results, ALA has proven to be a promising candidate in the combat arena against cancer.
